PASUT, GIANFRANCO
PASUT, GIANFRANCO
Dipartimento di Scienze del Farmaco - DSF
Tumor targeting of doxorubicin bound to peg of different size and shape. 27th International Symposium on controlled release of bioactive materials.
2000 Veronese, F. M.; Schiavon, Oddone; Pasut, Gianfranco; Duncan, R.; Ford, J.; Andersson, L; Andersen, A. J.; Ferruti, P.; Vincenzi, V.; Cassidy, J.; Davies, J. W.; Orsolini, P.
(1-B-D-arabinofuranosyl)cytosine (Ara-C) polymer conjugates for controlled release
2001 Schiavon, O.; Pasut, Gianfranco; Marzano, Cristina; Orsolini, P.; Veronese, F. M.
Multibranched PEG to improve the conjugate loading of Ara-C
2002 Schiavon, Oddone; Pasut, Gianfranco; Veronese, F. M.
Peg-doxorubicin conjugates with high loading
2003 Schiavon, Oddone; T., Vianello; Pasut, Gianfranco; Veronese, Francesco
Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates
2003 Furin, A; Guiotto, A; Baccichetti, F; Pasut, Gianfranco; Deuschel, C; Bertani, Roberta; Veronese, Francesco
Poly(ethylene glycol) (PEG)- malonato-Pt DACH conjugates
2003 Veronese, Francesco; A., Furin; A., Guiotto; F., Baciccchetti; Pasut, Gianfranco; C., Deuschel; Bertani, Roberta
99mTechnetium labeling of pegylated PN2S ligand in presence or absence of tin (II)
2003 Visentin, Roberta; Pasut, Gianfranco; Giron, MARIA CECILIA; Bello, Michele; M., Schiavon; F. M., Veronese; Mazzi, Ulderico
Kinetic Interaction Analysis of Human Interleukin 5 Receptor á Mutants Reveals a Unique Mechanism of Cytokine Recognition in the Class I Cytokine Receptor Family
2003 Ishino, T.; Pasut, Gianfranco; Scibek, J.; Chaiken, I.
MARCATURA DEL LEGANTE PN2S-PEG CON 99MTECNEZIO IN PRESENZA O IN ASSENZA DI STAGNO(II)
2003 Visentin, R.; Pasut, Gianfranco; Giron, M. G.; Bello, M.; Veronese, F. M.; Mazzi, U.
Preparation and biological studies of pegylated epirubicin
2004 Schiavon, O.; Pasut, Gianfranco; DALLA VIA, L.; Vitiello, Libero; Veronese, Fm
PEGylation of PN2S chelating agent: an efficient micelle-based method for the development of 99mTechnetium and 188Rhenium radiopharmaceuticals useful for tumor diagnosis and treatment
2004 Pasut, Gianfranco; Visentin, R.; Mazzi, U.; Veronese, F. M.
PEG-Ara-C conjugates for controlled release
2004 Schiavon, Oddone; Pasut, Gianfranco; Moro, Stefano; Orsolini, P; Guiotto, A; Veronese, Fm
Synthesis and Pharmacokinetic studies of dendritic PEG-epirubicin
2004 Pasut, Gianfranco; Scaramuzza, S.; Schiavon, Oddone; Veronese, F. M.
Synthesis and biological studies of PEG-epirubicin conjugates
2004 Schiavon, Oddone; Pasut, Gianfranco; DALLA VIA, L.; Vitiello, Libero; Veronese, Fm
Dendritic PEG-epirubicin conjugates with high loading
2004 Pasut, Gianfranco; Scaramuzza, S.; Schiavon, Oddone; Veronese, F. M.
NEW PEGYLATED CHELATING AGENT (mPEG-PN2S) SHOWED AN EASY LABELING METHOD WITH 99mTECHNETIUM USEFUL FOR TUMOUR DIAGNOSIS
2004 Pasut, Gianfranco; Visentin, Roberta; Mancin, Fabrizio; Mazzi, Ulderico; Veronese, F. M.
POLYETHYLENE GLYCOL CONJUGATES RELEASING NITRIC OXIDE
2004 Veronese, Fm; Pasut, Gianfranco
Kinetic Interaction Analysis of Human Interleukin 5 Receptor α Mutants Reveals a Unique Binding Topology and Charge Distribution for Cytokine Recognition
2004 Ishino, T; Pasut, Gianfranco; Scibek, J; Chaiken, I.
Highly efficient technetium-99m labeling procedure based on the conjugation of N-[N-(3-diphenylphosphinopropionyl)glycyl]cysteine ligand with poly(ethylene glycol)
2004 Visentin, Roberta; Pasut, Gianfranco; Veronese, Francesco; Mazzi, Ulderico
Protein, peptide and non-peptide drug PEGylation for therapeutical application: a review
2004 Pasut, Gianfranco; Guiotto, A; Veronese, Francesco